[1]
Song, Z. 2026. Daraxonrasib Treatment in RAS-Mutated Pancreatic Cancer: Mechanisms, Clinical Evidence and Future Perspectives. Transactions on Materials, Biotechnology and Life Sciences. 9, (Sep. 2026), 89–96. DOI:https://doi.org/10.62051/ndcdrx21.